| Emma Louise Musshorn, MD | |
|
10 Members Way Ste 203, Dover, NH 03820-5933 | |
| (603) 742-3174 | |
| Not Available |
| Full Name | Emma Louise Musshorn |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 10 Years |
| Location | 10 Members Way Ste 203, Dover, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265846331 | NPI | - | NPPES |
| 3109061 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 0101273111 (Virginia) | Primary |
| 207Q00000X | Family Medicine | 18021 (New Hampshire) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sentara Princess Anne Hospital | Virginia beach, VA | Hospital |
| Sentara Virginia Beach General Hospital | Virginia beach, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bayview Physician Services Pc | 5597664201 | 307 |
News Archive
The U.S. Food and Drug Administration today approved Coagadex, Coagulation Factor X (Human), for hereditary Factor X (10) deficiency. Until today's orphan drug approval, no specific coagulation factor replacement therapy was available for patients with hereditary Factor X deficiency.
The study, published August 9, 2004 in the online edition of CANCER, a peer-reviewed journal of the American Cancer Society, demonstrates that fewer surgeries per year negatively impacted patient standard of care. A free abstract of the study is available at CANCER Online.
According to a new study published in the latest issue of The Lancet, this week, more people across the globe are dying of sepsis than earlier believed. A team from the University of Pittsburgh and University of Washington schools of medicine led the research along with their colleagues from different disciplines.
Findings offered by a University of Kansas researcher, identified as one of 20 'Must See Presenters' at the national meeting of the American Chemical Society in early April, suggest a possible therapeutic intervention for "chemobrain," the cognitive impairment plaguing up to a third of cancer patients following chemotherapy.
› Verified 9 days ago
| Entity Name | Bayview Physician Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508813387 PECOS PAC ID: 5597664201 Enrollment ID: O20031231000719 |
News Archive
The U.S. Food and Drug Administration today approved Coagadex, Coagulation Factor X (Human), for hereditary Factor X (10) deficiency. Until today's orphan drug approval, no specific coagulation factor replacement therapy was available for patients with hereditary Factor X deficiency.
The study, published August 9, 2004 in the online edition of CANCER, a peer-reviewed journal of the American Cancer Society, demonstrates that fewer surgeries per year negatively impacted patient standard of care. A free abstract of the study is available at CANCER Online.
According to a new study published in the latest issue of The Lancet, this week, more people across the globe are dying of sepsis than earlier believed. A team from the University of Pittsburgh and University of Washington schools of medicine led the research along with their colleagues from different disciplines.
Findings offered by a University of Kansas researcher, identified as one of 20 'Must See Presenters' at the national meeting of the American Chemical Society in early April, suggest a possible therapeutic intervention for "chemobrain," the cognitive impairment plaguing up to a third of cancer patients following chemotherapy.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emma Louise Musshorn, MD 1925 Glenn Mitchell Dr, Ste 100, Virginia Beach, VA 23456-0170 Ph: (757) 689-8430 | Emma Louise Musshorn, MD 10 Members Way Ste 203, Dover, NH 03820-5933 Ph: (603) 742-3174 |
News Archive
The U.S. Food and Drug Administration today approved Coagadex, Coagulation Factor X (Human), for hereditary Factor X (10) deficiency. Until today's orphan drug approval, no specific coagulation factor replacement therapy was available for patients with hereditary Factor X deficiency.
The study, published August 9, 2004 in the online edition of CANCER, a peer-reviewed journal of the American Cancer Society, demonstrates that fewer surgeries per year negatively impacted patient standard of care. A free abstract of the study is available at CANCER Online.
According to a new study published in the latest issue of The Lancet, this week, more people across the globe are dying of sepsis than earlier believed. A team from the University of Pittsburgh and University of Washington schools of medicine led the research along with their colleagues from different disciplines.
Findings offered by a University of Kansas researcher, identified as one of 20 'Must See Presenters' at the national meeting of the American Chemical Society in early April, suggest a possible therapeutic intervention for "chemobrain," the cognitive impairment plaguing up to a third of cancer patients following chemotherapy.
› Verified 9 days ago
Dr. William L Yeaton, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 34 Ash St, Dover, NH 03820 Phone: 603-749-6532 | |
Peter Joseph Degnan, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 15 Old Rollinsford Road, Suite 204, Dover, NH 03820 Phone: 603-516-4255 Fax: 603-516-4254 | |
Michelle Sarah Mancherje, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Members Way, Dover, NH 03820 Phone: 603-742-3174 | |
William E Hassett, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Members Way, Suite 203, Dover, NH 03820 Phone: 603-742-3174 Fax: 603-742-1855 | |
Rachel Kaiser, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Members Way Ste 203, Dover, NH 03820 Phone: 603-742-3174 Fax: 603-742-1855 | |
Amanda Iantosca, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Members Way, Suite 203, Dover, NH 03820 Phone: 603-742-3174 Fax: 603-742-1855 |